Clinical Trial Supply and Logistics

Global Clinical Trial Supply and Logistics Market to Reach US$5.2 Billion by 2030

The global market for Clinical Trial Supply and Logistics estimated at US$3.8 Billion in the year 2024, is expected to reach US$5.2 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Logistics & Distribution Services, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Comparator Sourcing Services segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 8.9% CAGR

The Clinical Trial Supply and Logistics market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Clinical Trial Supply and Logistics Market - Key Trends and Drivers Summarized

Clinical trial supply and logistics play a critical role in the successful execution of clinical research. This specialized field encompasses the sourcing, management, and distribution of investigational products, as well as the necessary equipment and ancillary supplies to clinical trial sites. Ensuring that these components are delivered on time, in the right condition, and in compliance with regulatory standards is paramount to maintaining the integrity of the clinical trial process. This intricate logistics network involves coordination between pharmaceutical companies, contract research organizations (CROs), and various supply chain partners, each contributing to the seamless operation of clinical trials across multiple regions.

Recent advancements in clinical trial supply and logistics are significantly enhancing efficiency and reliability. Technology integration, such as real-time tracking and monitoring systems, has improved the visibility and management of supply chains, enabling stakeholders to track shipments accurately and respond swiftly to any issues that arise. Innovations in packaging and cold chain logistics are also crucial, particularly for biologics and other temperature-sensitive products that require stringent storage conditions. Additionally, the use of blockchain technology is emerging as a transformative tool for ensuring data integrity and traceability throughout the supply chain, thus enhancing transparency and security in clinical trial operations.

The growth in the clinical trial supply and logistics market is driven by several factors. Firstly, the increasing complexity and globalization of clinical trials necessitate robust logistics solutions to manage multi-site studies and diverse regulatory environments. Secondly, the rise in biologics and personalized medicine, which often require specialized handling and storage, is propelling demand for advanced logistics capabilities. Furthermore, technological advancements such as real-time tracking, AI-driven predictive analytics, and blockchain are revolutionizing the supply chain management, making it more efficient and reliable. The COVID-19 pandemic has also underscored the importance of agile and resilient supply chains, prompting greater investment in supply chain infrastructure. Additionally, the growing outsourcing trend among pharmaceutical companies to CROs for clinical trial logistics services is expanding market opportunities. Lastly, stringent regulatory requirements for clinical trial supplies are driving the adoption of comprehensive logistics solutions to ensure compliance and mitigate risks.

SCOPE OF STUDY:

The report analyzes the Clinical Trial Supply and Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Service (Logistics & Distribution Services; Comparator Sourcing Services; Manufacturing Services; Packaging, Labeling, & Blinding Services; Storage & Retention Services; Other Services); Trial Phase (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV Trials); Application (Cardiovascular Diseases Application, Oncology Application, Respiratory Diseases Application, CNS & Mental Disorders Application, Other Applications); End-Use (Pharmaceutical End-Use, Medical Devices End-Use, Biologicals End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 56 Featured) -

• Almac Group
• Bilcare Ltd.
• Biocair International Ltd.
• Catalent, Inc.
• Eurofins Scientific SE
• Experic
• ICON plc
• Intertek Group PLC
• IQVIA Inc.
• Lonza Group Ltd.
• Movianto
• Oximio
• Parexel International (MA) Corporation
• PCI Pharma Services
• Piramal Pharma Solutions

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.